64 -12 (50) 2022 — Vepritskaya Elena Vadimovna — THE ROLE OF THE SYMPATHOADRENAL SYSTEM IN THE DEVELOPMENT OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND INSULIN RESISTANCE

THE ROLE OF THE SYMPATHOADRENAL SYSTEM IN THE DEVELOPMENT OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND INSULIN RESISTANCE

Vepritskaya Elena Vadimovna Andijan State Medical Institute

Resume

The article considers the mechanisms of formation of insulin resistance, as well as endothelial dysfunction in conditions of insulin resistance, leading to cardiovascular complications, and a new approach to the correction of these disorders.

Key words: diabetes mellitus, sympathoadrenal system, insulin resistance, arterial hypertension.

First page

375

Last page

378

For citation: Vepritskaya Elena Vadimovna – THE ROLE OF THE SYMPATHOADRENAL SYSTEM IN THE DEVELOPMENT OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND INSULIN RESISTANCE //New Day in Medicine 12(50)2022 375-378 https://clck.ru/33BBM8

LIST OF REFERENCES:

1. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. /М.: ГЭОТАР-Медиа; 2014.
2. Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. //Сахарный диабет. 2017;20(1):13–41.
3. Демидова Т.Ю. Этиопатогенетическая роль инсулинорезистентности в развитии метаболических и сосудистых нарушений при сахарном диабете 2 типа. //Фарматека. 2010;16(210):18–24.
4. Покровский В.И., Виноградов Н.А. Оксид азота, его физиологические и патофизиологические свойства. Терапевтический архив. 2005;1:82–87.
5. Baron A.D. Insulin resistance and vascular function. J Diabetes Complications. 2002;16(1):92–102.
6. Gutiérrez-Rodelo C., Roura-Guiberna A., and Alberto Olivares-Reyes J. Molecular Mechanisms of Insulin Resistance: An Update. //Gaceta medica de Mexico; 2017.
7. Hubbard S.R. The insulin receptor: both a prototypical and atypical receptor tyrosine kinase. //Cold Spring Harb Perspect Biol. 2013; 5(3): a008946.
8. Jensen M., De Meyts P. Molecular mechanisms of differential intracellular signaling from the insulin receptor. //Vitam Horm. 2009; 80:51–75.
9. Kuboki K., Jiang Z.Y., Takahara N. et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. //Circulation. 2000; 101:676–681.
10. Muniyappa R., Montagnani M., Koh K.K., Quon M.J. Cardiovascular actions of insulin. //Endocr Rev. 2007; 28(5):463–491.
11. Rask-Madsen C., King G.L. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. //Nat Clin Pract Endocrinol Metab. 2007; 3:46–56.
12. Samuel V.T., Shulman G. Mechanisms for insulin resistance: Common threads and missing links. //Cell. 2012; 148:852–871.
13. White M.F. IRS proteins and the common path to diabetes. //Am J Physiol Endocrinol Metab. 2002; 283(3): F413– F422.